SOX12 Promotes Thyroid Cancer Cell Proliferation and Invasion by Regulating the Expression of POU2F1 and POU3F1

키워드

참고문헌 (35)

1. Li P, "Downregulation of CDH16 in papillary thyroid cancer and its potential molecular mechanism analysed by qRT-PCR, TCGA and in silico analysis", Cancer Manag Res, 11, pp.10719~10729 (2019)
2. Sugino K, "Risk stratification of pediatric patients with differentiated thyroid cancer : is total thyroidectomy necessary for patients at any risk?", Thyroid, 30, pp.548~556 (2020)
3. Li J, "Risk factors of deterioration in quality of life scores in thyroid cancer patients after thyroidectomy", Cancer Manag Res, 11, pp.10593~10598 (2019)
4. Jamora RDG, "Blepharospasm as the presenting feature of papillary thyroid cancer and parathyroid adenoma", J Clin Neurosci, 72, pp.460~463 (2020)
5. Shih SR, "Computerized cytological features for papillary thyroid cancer diagnosis-preliminary report", Cancers(Basel), 11, pp.1645~ (2019)
6. Fleeman N, "A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodine", BMC Cancer, 19, pp.1209~ (2019)
7. Huang J, "Treatment of aggressive thyroid cancer", Surg Pathol Clin, 12, pp.943~950 (2019)
8. Li J, "The roles of Sox family genes in sarcoma", Curr Drug Targets, 17, pp.1761~1772 (2016)
9. She ZY, "SOX family transcription factors involved in diverse cellular events during development", Eur J Cell Biol, 94, pp.547~563 (2015)
10. Qu M, "MicroRNA-138 inhibits SOX12 expression and the proliferation, invasion and migration of ovarian cancer cells", Exp Ther Med, 16, pp.1629~1638 (2018)
11. Du F, "Sex determining region Y-box 12(SOX12)promotes gastric cancer metastasis by upregulating MMP7 and IGF1", Cancer Lett, 452, pp.103~118 (2019)
12. Song Zou, "Sox12 Is a Cancer Stem-Like Cell Marker in Hepatocellular Carcinoma", Molecules and Cells, 40(11), pp.847~854 (2017), 한국분자세포생물학회
13. Du F, "SOX12 promotes colorectal cancer cell proliferation and metastasis by regulating asparagine synthesis", Cell Death Dis, 10, pp.239~ (2019)
14. Yuan P, "SOX12 upregulation is associated with metastasis of hepatocellular carcinoma and increases CDK4 and IGF2BP1 expression", Eur Rev Med Pharmacol Sci, 21, pp.3821~3826 (2017)
15. Wan H, "SOX12 : a novel potential target for acute myeloid leukaemia", Br J Haematol, 176, pp.421~430 (2017)
16. Gao Y, "SOX12 promotes the growth of multiple myeloma cells by enhancing Wnt", β-catenin signaling, 2020, pp.388, 111814~
17. You J, "SOX5 promotes cell invasion and metastasis via activation of Twist-mediated epithelial-mesenchymal transition in gastric cancer", Onco Targets Ther, 12, pp.2465~2476 (2019)
18. Sun R, "SOX4 contributes to the progression of cervical cancer and the resistance to the chemotherapeutic drug through ABCG2", Cell Death Dis, 6, pp.e1990~ (2015)
19. Tang H, "SOX8 acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer", Carcinogenesis, 40, pp.1278~1287 (2019)
20. Wang L, "Knockdown of SOX12 expression inhibits the proliferation and metastasis of lung cancer cells", Am J Transl Res, 9, pp.4003~4014 (2017)
21. Ding H, "Silencing of SOX12 by shRNA suppresses migration, invasion and proliferation of breast cancer cells", Biosci Rep, 36, pp.e00389~ (2016)
22. Gómez-Hidalgo NR, "Oncologic impact of micrometastases or isolated tumor cells in sentinel lymph nodes of patients with endometrial cancer : a meta-analysis", Clin Transl Oncol, 22, pp.1272~1279 (2020)
23. Surov A, "Standardized uptake values derived from 18F-FDG PET may predict lung cancer microvessel density and expression of KI 67, VEGF, and HIF-1α but not expression of cyclin D1, PCNA, EGFR, PD L1, and p53", Contrast Media Mol Imaging, 2018, pp.9257929~ (2018)
24. Søgaard CK, "Targeting the non-canonical roles of PCNA modifies and increases the response to targeted anti-cancer therapy", Oncotarget, 10, pp.7185~7197 (2019)
25. Juríková M, "Ki67, PCNA, and MCM proteins : markers of proliferation in the diagnosis of breast cancer", Acta Histochem, 118, pp.544~552 (2016)
26. Jeon S, "CCND1 splice variant as a novel diagnostic and predictive biomarker for thyroid cancer", Cancers(Basel), 10, pp.437~ (2018)
27. Guo F, "Long non-coding RNA NR2F1-AS1promoted proliferation and migration yet suppressed apoptosis of thyroid cancer cells through regulating miRNA-338-3p", CCND1axis, 2019, pp.23, 5907~5919
28. Zhou C, "E-cadherin expression is associated with susceptibility and clinicopathological characteristics of thyroid cancer : a PRISMA-compliant meta-analysis", Medicine(Baltimore), 98, pp.e16187~ (2019)
29. Sheng L, "Effect of slug-mediated down-regulation of E-cadherin on invasiveness and metastasis of anaplastic thyroid cancer cells", Med Sci Monit, 23, pp.138~143 (2017)
30. Rajoria S, "Estrogen induced metastatic modulators MMP-2and MMP-9 are targets of 3, 3'-diindolylmethane in thyroid cancer", PLoS One, 6, pp.e15879~ (2011)
31. Alrehaili AA, "Clinical significance of plasma MMP-2 and MMP-9 levels as biomarkers for tumor expression in breast cancer patients in Egypt", Mol Biol Rep, 47, pp.1153~1160 (2020)
32. Liu Y, "miR-449a promotes liver cancer cell apoptosis by downregulation of Calpain 6and POU2F1", Oncotarget, 7, pp.13491~13501 (2016)
33. Sharpe DJ, "POU2F1 activity regulates HOXD10 and HOXD11 promoting a proliferative and invasive phenotype in head and neck cancer", Oncotarget, 5, pp.8803~8815 (2014)
34. Wang SM, "POU2F2-oriented network promotes human gastric cancer metastasis", Gut, 65, pp.1427~1438 (2016)
35. Ding S, "LncRNA BCYRN1", miR-490-3p, Cancer Cell Int, pp.2020, 20[DOI]

관련 논문AI추천